JP2025521102A5 - - Google Patents

Info

Publication number
JP2025521102A5
JP2025521102A5 JP2024566858A JP2024566858A JP2025521102A5 JP 2025521102 A5 JP2025521102 A5 JP 2025521102A5 JP 2024566858 A JP2024566858 A JP 2024566858A JP 2024566858 A JP2024566858 A JP 2024566858A JP 2025521102 A5 JP2025521102 A5 JP 2025521102A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
seq
molecule according
splicing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025521102A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066969 external-priority patent/WO2023220742A2/en
Publication of JP2025521102A publication Critical patent/JP2025521102A/ja
Publication of JP2025521102A5 publication Critical patent/JP2025521102A5/ja
Pending legal-status Critical Current

Links

JP2024566858A 2022-05-13 2023-05-12 Abca4トランススプライシング分子 Pending JP2025521102A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263341665P 2022-05-13 2022-05-13
US63/341,665 2022-05-13
US202363478472P 2023-01-04 2023-01-04
US63/478,472 2023-01-04
PCT/US2023/066969 WO2023220742A2 (en) 2022-05-13 2023-05-12 Abca4 trans-splicing molecules

Publications (2)

Publication Number Publication Date
JP2025521102A JP2025521102A (ja) 2025-07-08
JP2025521102A5 true JP2025521102A5 (cg-RX-API-DMAC7.html) 2026-05-19

Family

ID=88731152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566858A Pending JP2025521102A (ja) 2022-05-13 2023-05-12 Abca4トランススプライシング分子

Country Status (11)

Country Link
US (3) US20240042057A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522758A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025521102A (cg-RX-API-DMAC7.html)
KR (1) KR20250011939A (cg-RX-API-DMAC7.html)
CN (1) CN119731328A (cg-RX-API-DMAC7.html)
AU (1) AU2023269865A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252043A1 (cg-RX-API-DMAC7.html)
GB (1) GB2634434A (cg-RX-API-DMAC7.html)
IL (1) IL316944A (cg-RX-API-DMAC7.html)
MX (1) MX2024014029A (cg-RX-API-DMAC7.html)
WO (1) WO2023220742A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250150157A (ko) 2018-04-17 2025-10-17 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 트랜스-스플라이싱 분자
KR20250011939A (ko) 2022-05-13 2025-01-22 아시디엔 테라퓨틱스, 인크. Abca4 트랜스-스플라이싱 분자
WO2025217174A1 (en) 2024-04-08 2025-10-16 The Broad Institute, Inc. Aav capsid modifications that enable improved cns-wide gene delivery through interactions with carbonic anhydrase iv
WO2025217163A2 (en) 2024-04-08 2025-10-16 The Broad Institute, Inc. Novel aav capsids binding to human cd59
US12686869B1 (en) 2026-01-23 2026-07-21 Amber Bio Inc. Methods and compositions for trans-splicing utilizing trifunctional elements

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0883344B2 (en) 1995-12-15 2010-06-09 VIRxSYS Corporation Therapeutic molecules generated by trans-splicing
US6280978B1 (en) 1995-12-15 2001-08-28 Intronn Holdings, Llc Methods and compositions for use in spliceosome mediated RNA trans-splicing
EP0938381B1 (en) 1996-10-04 2012-12-26 Veri-Q Inc. Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation
US6929907B2 (en) 1999-12-31 2005-08-16 North Carolina State University Methods and compositions for determining the purity of chemically synthesized nucleic acids
CA2452690C (en) 2001-06-29 2016-08-16 Veri-Q, Inc. Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids
AU2003215249B2 (en) 2002-02-12 2008-07-03 Virxsys Corporation Methods and compositions for use in spliceosome mediated RNA trans-splicing
US7399753B2 (en) 2002-02-25 2008-07-15 Virxsys Corporation Trans-splicing mediated photodynamic therapy
CA2477295A1 (en) 2002-02-25 2003-09-04 Intronn, Inc. Trans-splicing mediated imaging of gene expression
AU2003247505A1 (en) 2002-06-05 2003-12-22 University Of Iowa Research Foundation Spliceosome mediated rna trans-splicing in stem cells
WO2003104412A2 (en) 2002-06-05 2003-12-18 Intronn, Inc. Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
US20040018622A1 (en) 2002-07-17 2004-01-29 Mitchell Lloyd G. Spliceosome mediated RNA trans-splicing for correction of skin disorders
AU2003285009B2 (en) 2002-10-23 2010-10-07 Virxsys Corporation Screening methods for identification of efficient pre-trans-splicing molecules
WO2005070948A1 (en) 2004-01-23 2005-08-04 Intronn, Inc. Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing
US7968334B2 (en) 2004-01-23 2011-06-28 Virxsys Corporation Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
WO2005070023A2 (en) 2004-01-23 2005-08-04 Intronn, Inc. Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
WO2006026611A2 (en) 2004-08-31 2006-03-09 Mitchell Lloyd G Reverse transcriptase mediated rna gene expression
US7943374B2 (en) 2005-08-21 2011-05-17 Markus Hildinger Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
US20090214478A1 (en) 2008-02-21 2009-08-27 Alberto Auricchio Method of treating ocular diseases by gene therapy
US8236557B2 (en) 2008-05-28 2012-08-07 University Of Missouri-Columbia Hybrid-AAV vectors to deliver large gene expression cassette
EP2151248A1 (en) 2008-07-30 2010-02-10 Johann Bauer Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses
EP2486136B1 (en) 2009-10-08 2016-03-30 Association Institut de Myologie Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
US8648053B2 (en) 2010-10-20 2014-02-11 Rosalind Franklin University Of Medicine And Science Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome
US9249425B2 (en) 2011-05-16 2016-02-02 The Trustees Of The University Of Pennslyvania Proviral plasmids and production of recombinant adeno-associated virus
ES2646716T3 (es) 2011-09-05 2017-12-15 Stichting Katholieke Universiteit Oligonucleótidos antisentido para el tratamiento de amaurosis congénita de Leber
CN105120901A (zh) 2012-07-11 2015-12-02 宾夕法尼亚大学托管会 Rpgr x染色体连锁视网膜退化的aav介导的基因治疗
CN104955951A (zh) 2012-10-16 2015-09-30 麻省理工学院 稳定的非多腺苷酸化rna的产生
DK2986635T3 (en) 2013-04-18 2019-01-28 Fond Telethon EFFECTIVE DELIVERY OF BIG GENES THROUGH DUAL-AAV VECTORS
US9938521B2 (en) 2014-03-10 2018-04-10 Editas Medicine, Inc. CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)
LT3167076T (lt) * 2014-07-09 2022-02-10 Lexogen Gmbh Metodai ir produktai, skirti rnr transkripto variantų kiekybiniam įvertinimui
CN107109411B (zh) 2014-10-03 2022-07-01 冷泉港实验室 核基因输出的定向增加
AU2016355343C1 (en) * 2015-11-19 2024-10-03 Lloyd G. Mitchell Compositions and methods for correction of heritable ocular disease
JP7036723B2 (ja) 2015-12-14 2022-03-15 コールド スプリング ハーバー ラボラトリー 眼疾患の処置のための組成物および方法
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
WO2017171654A1 (en) 2016-04-01 2017-10-05 National University Of Singapore Trans-splicing rna (tsrna)
US11795455B2 (en) 2017-07-31 2023-10-24 Massachusetts Institute Of Technology RNA cleavage-induced transcript stabilizer and uses thereof
KR20260009385A (ko) 2017-08-25 2026-01-19 스톡 테라퓨틱스, 인크. 병태 및 질환 치료용 안티센스 올리고머
MX2020009579A (es) * 2018-03-15 2020-11-09 Intergalactic Therapeutics Inc Vectores de adn sintetico y metodos de uso.
KR20250150157A (ko) * 2018-04-17 2025-10-17 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 트랜스-스플라이싱 분자
BR112021020539A2 (pt) 2019-04-17 2022-01-04 Univ Pennsylvania Terminador de hélice tripla para trans-splicing de rna eficiente
WO2020214990A1 (en) * 2019-04-17 2020-10-22 Ascidian Therapeutics, Inc. Abca4 cell line and methods of use
CN113795155A (zh) * 2019-05-01 2021-12-14 宝洁公司 产生短链脂肪酸的益生菌菌株和包含该益生菌菌株的组合物
EP4013873A1 (en) 2019-08-16 2022-06-22 Massachusetts Institute Of Technology Targeted trans-splicing using crispr/cas13
WO2021076656A1 (en) 2019-10-15 2021-04-22 University Of Massachusetts Rna editor-enhanced rna trans-splicing
EP3992292A4 (en) 2020-02-28 2023-06-21 Rznomics Inc. APOE4 RNA-SPECIFIC TRANSSPLICING RIBOZYME AND ITS USE
EP4217010A4 (en) 2020-09-28 2025-01-08 Tacit Therapeutics, Inc. TRANS-SPLICING SYSTEM FOR TISSUE-SPECIFIC REPLACEMENT OF RNA SEQUENCES
EP4323391A4 (en) 2021-04-15 2025-04-16 Tacit Therapeutics, Inc. HIGH-EFFICIENCY TRANS-SPLICING FOR TARGETED RNA SEQUENCE REPLACEMENT IN HUMAN CELLS
JP2024533163A (ja) 2021-09-03 2024-09-12 タシト・セラピューティクス・インコーポレーテッド スプライソソーム構成要素のリクルートを介したrna編集
WO2023205694A2 (en) 2022-04-20 2023-10-26 Tacit Therapeutics, Inc. Stabilization of therapeutic trans-splicing rna molecules in human cells
EP4519436A4 (en) 2022-05-03 2026-08-19 Tacit Therapeutics Inc LOCALIZATION OF NUCLEIC ACID MOLECULES TRANS-SPLICING TO AND WITHIN THE CELL NUCLEUS
KR20250011939A (ko) 2022-05-13 2025-01-22 아시디엔 테라퓨틱스, 인크. Abca4 트랜스-스플라이싱 분자

Similar Documents

Publication Publication Date Title
JP7349931B2 (ja) 高ビリルビン血症の処置
US12246072B2 (en) Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa
JP2024099770A5 (cg-RX-API-DMAC7.html)
JP2021531752A5 (cg-RX-API-DMAC7.html)
CN111902539A (zh) 杂合调控元件
US10016514B2 (en) Polynucleotides, vectors and methods for insertion and expression of transgenes
CN120324641A (zh) 用于治疗达农病的基因治疗载体
JP2021520837A5 (cg-RX-API-DMAC7.html)
CN104936606A (zh) 糖原贮积病的基因疗法
JP7759174B2 (ja) 繊毛病のための遺伝子治療
US20200263199A1 (en) Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
EP3952920A1 (en) Hybrid promoters for muscle expression
US20020076754A1 (en) Overcoming AAV vector size limitation through viral DNA hetero-dimerization
KR20210096168A (ko) 신경퇴행성 질환을 위한 유전자 요법
GB2634434A (en) ABCA4 trans-splicing molecules
JP7752148B2 (ja) 筋強直性ジストロフィーの処置
JP2021520232A5 (cg-RX-API-DMAC7.html)
JP2022529500A5 (cg-RX-API-DMAC7.html)
US20240100132A1 (en) Modulation of aav-based gene expression
Dhooge et al. Gene therapy for inherited retinal diseases
CN121127272A (zh) 用于治疗眼底黄色斑点症的双aav载体
HK40010983A (en) Nucleic acids comprising a modified intron for use in the treatment of hyperbilirubinemia
HK1234780B (en) Treatment of hyperbilirubinemia
HK1234780A1 (en) Treatment of hyperbilirubinemia